FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 352:2155-2157 May 26, 2005 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

On March 21, 2005, the Centers for Disease Control and Prevention (CDC) in Atlanta confirmed the presence of Marburg virus in 9 of 12 patient samples of tissue and blood sent for analysis by health authorities in Angola. The samples came from a growing number of patients, almost all of them linked to a single pediatric ward in the main hospital in Uige Province, who were rapidly dying from an unknown disease with hemorrhagic manifestations. The identity of the causative agent came as a surprise: Marburg hemorrhagic fever is an exceedingly rare disease, and there had never been a case . . . [Full Text of this Article]

Source Information

Dr. Ndayimirije is an epidemiologist at the World Health Organization (WHO) in Brazzaville, Congo, and Ms. Kindhauser is a science writer at WHO in Geneva.

Related Letters:

Lessons from the Outbreak of Marburg Virus
Borchert M., Mulangu S., Van der Stuyft P.
Extract | Full Text | PDF  
N Engl J Med 2005; 353:1185, Sep 15, 2005. Correspondence

This article has been cited by other articles:

• Swenson, D. L., Wang, D., Luo, M., Warfield, K. L., Woraratanadharm, J., Holman, D. H., Dong, J. Y., Pratt, W. D. (2008). Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections. CVI 15: 460-467 [Abstract] [Full Text]  
• Borchert, M., Mulangu, S., Van der Stuyft, P. (2005). Lessons from the Outbreak of Marburg Virus. NEJM 353: 1185-1185 [Full Text]